The value of serial plasma nuclear and mitochondrial DNA levels in acute spontaneous intra-cerebral haemorrhage

European Journal of Neurology

Volumn 19, Issue 12, 2012, Pages 1532-1538

  Wang, H C ^a,b   Lin, Y J ^a,c   Lin, W C ^a   Ho, J T ^a   Chen, W F ^a   Chang, W N ^a   Tsai, N W ^a   Lu, C H ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Outcome; Plasma mitochondrial DNA; Plasma nuclear DNA; Spontaneous intra cerebral haemorrhage

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA;

ACUTE BRAIN DISEASE; ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN HEMORRHAGE; BRAIN INJURY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIECTOMY; CRANIOTOMY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURGICAL DRAINAGE; TREATMENT OUTCOME;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CELL NUCLEUS; CEREBRAL HEMORRHAGE; DNA; DNA, MITOCHONDRIAL; FEMALE; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84869491426     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03761.x     Document Type: Article

References (23)

1. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993; 24: 796-800.
2. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996; 27: 373-380.
3. Mayo NE, Neville D, Kirkland S, et al. Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke 1996; 27: 1215-1220.
4. Wu TL, Zhang D, Chia JH, Tsao KH, Sun CF, Wu JT. Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 2002; 321: 77-87.
5. Fournié GJ, Martres F, Pourrat JP, Alary C, Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology 1993; 39: 215-221.
6. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006; 10: R60.
7. Rainer TH, Wong LK, Lam W, et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003; 49: 562-569.
8. Lam NY, Rainer TH, Wong LK, Lam W, Lo YM. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset. Resuscitation 2006; 68: 71-78.
9. Rainer TH, Wong KS, Lam W, Lam NY, Graham CA, Lo YM. Comparison of plasma beta-globin DNA and S-100 protein concentrations in acute stroke. Clin Chim Acta 2007; 376: 190-196.
10. Tsai NW, Lin TK, Chen SD, et al. The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke. Clin Chim Acta 2011; 412: 476-479.
11. Lam NY, Rainer TH, Chan LY, Joynt GM, Lo YM. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 2003; 49: 1286-1291.
12. Lu CH, Chang WN, Tsai NW, Chuang YC, Huang CR, Wang HC. The value of serial plasma nuclear and mitochondrial DNA levels in adult community-acquired bacterial meningitis. QJM 2010; 103: 169-175.
13. Bamford JM, Sandercock PAG, Warlow CP, et al. Inter-observer agreement for the assessment of handicap in stroke patients [letter]. Stroke 1989; 20: 828.
14. World Health Organization. Cerebrovascular Disease, Prevention, Treatment and Rehabilitation. Geneva: World Health Organization, 1971, WHO Tech Rep Ser No 469.
15. Chiu RW, Chan LY, Lam NY, et al. Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 2003; 49: 719-726.
16. Lo YM, Tein MS, Lau TK, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
17. Tsumita T, Iwanagam M. Fate of injected deoxyribonucleic acid in mice. Nature 1963; 198: 1088-1089.
18. Tsai NW, Lin TK, Chang WN, et al. Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care 2011; 15: R163.
19. Leker RR, Khoury ST, Rafaeli G, Shwartz R, Eichel R, Tanne D. NASIS Investigators: Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009; 40: 2581-2584.
20. White HD, Simes RJ, Anderson NE, et al. Pravastatin therapy and the risk of stroke. N Engl J Med 2000; 343: 317-326.
21. Qureshi AI, Ling GS, Khan J, et al. Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage. Crit Care Med 2001; 29: 152-157.
22. Kwak BR, Mach F. Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arterioscler Thromb Vasc Biol 2001; 21: 1256-1258.
23. Veillard NR, Mach F. Statins: the new aspirin? Cell Mol Life Sci 2002; 59: 1771-1786.